stockportfolio.pro
Stocks / ELV vs MDLN
ELV vs MDLN
Elevance Health, Inc. and Medline Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Elevance Health, Inc. (ELV) | Medline Inc. (MDLN) | |
|---|---|---|
| Market cap | $87.3B | $64.5B |
| Revenue (latest FY) | $197.58B | $28.43B |
| Net income (latest FY) | $5.66B | $1.16B |
| Revenue growth (5y CAGR) | 10.1% | 7.0% |
| Net margin | 2.9% | 4.1% |
| Return on equity | 12.9% | 10.8% |
| P/E ratio | 17.0 | 31.8 |
| Dividend yield | 1.7% | — |
| Profitable years (of last 10) | 10 | 4 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ELV — free Open MDLN — freeFrequently asked questions
Which is bigger, ELV or MDLN?
Elevance Health, Inc. is larger by market capitalization — $87.3B versus $64.5B.
Which grows faster, ELV or MDLN?
Over the last five fiscal years, Elevance Health, Inc. grew revenue faster — 10.1%/yr versus 7.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.